This paper with Inozyme Pharma, published in Human Mutation, reveals how creating a comprehensive database of curated variants that is widely accessible is crucial for increasing diagnosis of ENPP1 Deficiency.
We help provide insights into key genetic drivers of diseases and relevant biomarkers. By working together to understand this data, we enable scientists and researchers to make more informed decisions on programs of interest. To learn more about how we can partner together to find your genomic variant solutions, we invite you to click on the link below.